Jens Eckstein

Jens Eckstein is a seasoned professional with over 20 years of experience in venture capital, entrepreneurship, and operational management in the biotechnology and biopharmaceutical sectors.

Having a background in Biological Chemistry and Drug Design, Jens has held various key positions in organizations and companies, including founder or co-founder roles in life science and healthcare IT startups.

Jens Eckstein is a Kauffman Fellow known for his contributions to the field. He has also created the OneStart business plan competition, showcasing his commitment to fostering innovation and supporting aspiring entrepreneurs in the life sciences.

His expertise spans venture capital investing, technology transfer, drug discovery, and development, as well as integrated healthcare IT solutions.

Jens' academic journey includes pursuing postdoctoral research at the University of California, San Francisco, and completing his Ph.D. in Biological Chemistry at the University of Konstanz. He has also been a visiting scholar at Harvard University and holds a Diplom in Chemistry from the University of Konstanz.

Throughout his career, Jens Eckstein has been associated with a range of organizations and companies in leadership roles. He has served as a board member, investment partner, advisor, and chairman in notable ventures such as Vandria SA, Hevolution Foundation, Galilei Biosciences, Booster Therapeutics, and many others.

His valuable contributions also extend to roles such as managing partner at Apollo Health Ventures, co-founder of Decibel Therapeutics, and director at Gladius Pharmaceuticals and SR One.

Jens Eckstein's professional expertise and diverse experience make him a sought-after figure in the life science industry, offering mentorship and strategic guidance to entrepreneurs and start-up teams in the field.